Overcoming Barriers to Uptake of Cascade Screening

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUNC Lineberger Comprehensive Cancer Center

About this trial

Lynch syndrome is a genetic condition that increases cancer risk. The public health impact of genetic testing for disease prevention hinges on cascade screening, which is the systematic identification and testing of blood relatives after a family member has been diagnosed with a genetic condition. Despite its importance in disease prevention, only half of first-degree relatives of individuals with Lynch syndrome undergo cascade screening. To address this gap, the study will pilot test an online version of Let's Talk, a novel intervention designed to support and promote cascade screening. This intervention tool is designed to support and encourage more family members to get screened. The purpose of this study aim is to assess the feasibility of the online Let's Talk tool in clinical use by examining implementation and effectiveness outcomes related to the use of the planning tool across three clinics at a large academic-affiliated medical center with patients (n=15) seen by one of five genetic counselors (n=5).

Eligibility criteria

Qualifiers

Written informed consent obtained to participate in the study.

Subject is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee.

Age ≥ 18 years at the time of consent.

Written informed consent obtained to participate in the study.

Disqualifiers

The patient has already notified all relatives about their diagnosis with Lynch syndrome.

Genetic Counselor is not employed.

Trial design

Treatments tested in this trial

  • Let's Talk Genetics Providers
  • Let's Talk Patients

Treatment groups

20 Participants
are divided into 2 treatment groups

Sponsors and collaborators

UNC Lineberger Comprehensive Cancer Center

Lead sponsor

National Institutes of Health (NIH)

Collaborator

National Human Genome Research Institute (NHGRI)

Collaborator